Randomized Study of 3,4-Diaminopyridine for Lambert-Eaton Myasthenic Syndrome - Contacts and Locations

Home

Randomized Study of 3,4-Diaminopyridine for Lambert-Eaton Myasthenic Syndrome

This study has been completed.

Study NCT00004832. Last updated on June 23, 2005. Information provided by FDA Office of Orphan Products Development

Please refer to this study by its ClinicalTrials.gov identifier: NCT00004832

Sponsors and Collaborators

FDA Office of Orphan Products Development

Duke University

Investigators


Study Chair:	Donald B. Sanders	Duke University